The global prostate malignant neoplasms mortality data for 2024 shows significant variation across countries, with Latvia, Estonia, and Denmark having the highest mortality rates, exceeding 47 male deaths per hundred thousand men. Conversely, Israel, South Korea, and Mexico display the lowest mortality rates, below 13. Unpacking the year-on-year changes for 2023, notable increases were seen in Iceland (4.67%), Peru (15.86%), and South Korea (4.29%), while decreases occurred in Sweden (-0.99%), Switzerland (-1.3%), and Chile (-1.41%). The 5-year compound annual growth rate (CAGR) further highlights the long-term upward trends in South Korea, Israel, and Peru, indicating a worsening situation in these regions.
Future trends to watch for in global prostate malignant neoplasms mortality include advancements in medical technology, public health initiatives targeting early detection, and lifestyle modifications that could significantly alter the trajectory of these mortality rates. Investments in healthcare systems, broader access to preventive care, and localized awareness programs will be crucial in mitigating mortality rates in countries with the highest current burdens.
Top countries in Prostate Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) Per Hundred Thousand Men | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Latvia | 50.2 | 2023 | +0.8% | +0.86% | View data |
| 2 | 2 Estonia | 47.9 | 2023 | +4.36% | +0.64% | View data |
| 3 | 3 Denmark | 47.4 | 2023 | +0.85% | +1.64% | View data |
| 4 | 4 Slovenia | 45 | 2023 | +1.58% | +0.96% | View data |
| 5 | 5 Sweden | 43 | 2023 | -0.92% | -0.99% | View data |
| 6 | 6 Croatia | 42.6 | 2023 | +1.67% | +1.19% | View data |
| 7 | 7 Portugal | 40.2 | 2023 | +0.75% | +0.92% | View data |
| 8 | 8 Germany | 38.1 | 2023 | +0.53% | +0.81% | View data |
| 9 | 9 Bulgaria | 37.7 | 2023 | +2.72% | +4.26% | View data |
| 10 | 10 United Kingdom | 37.4 | 2023 | +0.27% | +0.65% | View data |
